company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1520943.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3186696.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4707639.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4707639.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,108333.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,118772.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100887.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-90448.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4798087.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4798087.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4798087.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4798087.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.08
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.08
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,789222.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:16:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.08
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1422083.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3067995.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4490078.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4490078.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,112778.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61212.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-56131.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-107697.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4597775.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4597775.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4597775.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4597775.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.83
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.83
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,789222.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:14:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.83
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2420267.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2569931.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4990198.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4990198.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,113889.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38777.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35070.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-110182.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5100380.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5100380.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5100380.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5100380.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.46
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.46
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,789222.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 09:03:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.46
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1341004.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2236290.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3577294.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3577294.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,113889.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15238.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14537.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-113188.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3690482.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3690482.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3690482.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3690482.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.65
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.65
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,790038.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.65
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2283913.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4150847.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6434760.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6434760.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,111667.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30758.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26575.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-107484.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6542244.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6542244.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6542244.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6542244.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7632786.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:26:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2234232.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3614593.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5848825.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5848825.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,106037.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,134644.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-110384.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-81777.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5930602.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5930602.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5930602.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5930602.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15619151.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2304026.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4658293.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6962319.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6962319.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,96926.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,153122.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-129484.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-73288.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7035607.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7035607.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7035607.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7035607.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15624963.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 12:09:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2241755.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5499615.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7741370.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7741370.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,86740.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,160191.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-137292.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63841.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7805211.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7805211.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7805211.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7805211.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13900000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13900000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13893961.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2759832.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6255111.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9014943.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9014943.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,203468.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,168363.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-123475.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-158580.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9173523.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9173523.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9173523.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9173523.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21300000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21300000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21451317.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 09:26:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2904000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9640000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12544000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12544000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,440000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-332000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,108000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12436000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12436000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12436000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12436000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21400000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21400000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21475000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:16:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3197000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7829000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11026000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11026000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,202000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,274000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-182000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-110000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11136000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11136000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11136000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11136000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21400000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21400000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21507000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:31:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4511168.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8966889.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13478057.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13478057.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,165532.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,363637.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-289525.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-91420.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13569477.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13569477.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13569477.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13569477.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21500000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21500000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21497000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4692000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11981000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16673000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16673000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,276000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,336000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-202000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-142000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16815000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16815000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16815000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16815000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21600000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21570000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:03:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5215000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8905000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14120000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14120000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,202000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,295000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-158000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14185000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14185000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14185000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14185000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22500000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22500000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22666000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:35:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8388000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9047000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17435000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17435000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,561000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,421000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-207000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-347000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17782000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17782000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17782000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17782000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27400000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27400000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27524000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:38:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10171000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11381000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21552000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21552000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,709000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,469000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1320000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1560000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23112000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23112000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23112000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23112000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25300000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25300000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25297000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13026000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10756000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23782000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23782000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,632000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,557000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-97000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23879000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23879000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23879000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23879000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31704000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:03:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15133000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11769000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26902000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26902000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2887000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,797000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,112000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1978000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28880000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28880000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28880000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28880000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31700000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31700000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31826000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:06:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18375000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12846000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31221000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31221000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3843000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1095000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-219000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2967000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34188000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34188000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34188000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34188000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32000000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.07
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32000000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.07
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31931000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:06:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.07
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,355000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,355000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,351000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32267000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15860000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48127000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47776000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3906000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1269000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-121000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2758000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50534000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50534000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50534000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50534000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33000000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.43
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33000000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.43
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33027000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.43
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2194000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2194000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2698000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2698000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-504000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26899000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11551000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38450000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38954000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3919000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1161000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,143000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2615000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41569000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41569000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41569000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41569000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.1
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37620000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:03:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.1
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3797000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3797000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,946000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,946000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2851000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31036000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13094000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44130000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41279000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3926000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1254000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,76000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2596000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43875000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43875000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43875000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43875000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.16
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.16
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37697000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 16:06:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.16
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6990000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6990000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1619000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1619000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5371000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32804000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13578000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46382000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41011000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3930000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1157000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,144000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2629000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43640000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43640000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43640000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43640000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37900000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37900000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37818000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:06:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9543000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9543000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2073000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2073000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7470000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30572000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14856000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45428000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37958000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3937000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,995000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,325000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2617000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40575000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40575000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40575000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40575000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.08
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37800000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.08
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37751000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.08
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10564000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10564000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1762000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1762000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8802000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32222000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15424000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47646000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38844000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3936000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1011000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,231000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2694000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41538000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41538000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41538000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41538000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38100000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.09
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38100000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.09
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37992000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:05:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.09
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16953000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16953000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1398000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1398000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15555000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33103000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16125000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49228000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33673000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3949000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,831000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,304000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2814000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36487000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36487000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36487000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36487000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38000000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.96
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38000000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.96
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38010000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:04:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.96
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21786000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21786000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2872000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2872000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18914000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32136000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20938000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53074000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34160000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4652000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,721000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-141000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4072000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38232000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38232000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38232000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38232000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38200000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38200000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38125000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23654000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23654000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3928000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3928000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19726000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32248000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17072000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49320000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29594000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4529000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,649000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-42000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3922000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33516000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33516000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33516000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33516000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38100000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.88
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38100000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.88
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38086000.0
Flexion Therapeutics Inc,FLXN,549300X8HYW1HZKCDG90,0001419600,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.88
